Celldex Therapeutics | CLDX - Sales Revenues

Stock Price
28.22
Daily Change
-0.32 -1.12%
Monthly
19.88%
Yearly
41.45%
Q1 Forecast
28.62

Celldex Therapeutics reported $121K in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
AbbVie USD 16.62B 840M Dec/2025
Agenus USD 34.2M 3.97M Dec/2025
Amgen USD 9.9B 340M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Celldex Therapeutics USD 121K 769K Dec/2025
Glaxosmithkline GBP 11.52B 3.54B Sep/2025
Nektar Therapeutics USD 24.12M 635K Sep/2024
Northwest Biotherapeutics USD 445K 39K Dec/2023
Pfizer USD 17.58B 880M Dec/2025
Rigel Pharmaceuticals USD 55.31M 18.47M Sep/2024
Roche Holding CHF 15.65B 274.5M Dec/2025